These UPMC Children’s Hospital of Pittsburgh staff members recently received recognition in their fields.
In August, the UPMC Children’s Child Neurology Division welcomed a new epilepsy specialist, Ruba Al-Ramadhani, MD. Dr. Al-Ramadhani earned her medical degree from the University of Baghdad College of Medicine in 2008. She completed her pediatric and child neurology residencies at the University of Mississippi in 2019, followed by a fellowship in Clinical Neurophysiology-Pediatric Epilepsy at Emory University in Atlanta, Georgia, in 2020. After completing her fellowship, Dr. Al-Ramadhani joined the Emory University School of Medicine faculty as an Assistant Professor of Neurology, with a clinical appointment as Assistant Professor of Pediatric Neurology at Children’s Health Care of Atlanta and Brain Health Center, also in Atlanta. At UPMC Children’s, Dr. Al-Ramadhani joins The Epilepsy Center with a role in furthering the development of the Epilepsy Surgery Program.
In September, Brian Campfield, MD, was awarded an R01 award from the National Institutes of Health (NIH) for his project titled “Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia.” Dr. Campfield and team aim to determine the molecular and cellular requirements of FSTL-1-mediated pulmonary host defense pathway, and outcomes of these studies will inform host-derived, immune targeting therapeutic approaches for the treatment of bacterial pneumonia.
In June, Catherine S. Forster, MD, MS, FAAP, pediatric hospitalist and researcher at UPMC Children’s, received a Supporting Our Scientists (SOS) Award from the Institute for Clinical Research Education. SOS is a “year-long program that supports faculty members who have experienced undue caregiving responsibilities as a result of COVID” and whose research or career have been challenged due to their responsibilities. Aspects of the SOS award include research funding, career development and work-life integration. Dr. Forster will receive $35,000 for research, along with things like mentoring from certified coaches, participation in courses to grow their career like writing and presentation courses, and work-life integration help with a gift card that can be used to “pay for time-saving activities.”
In July, Dr. Forster and Maha Kaissi, MD, pediatric hospitalist, were awarded the Collaborative Impact Award at the Pediatric Hospital Medicine (PHM) Conference in Orlando, Florida. Dr. Forster and Dr. Kaissi, along with their colleagues in the APP’s Section of Hospital Medicine Women in Pediatric Hospital Medicine Sub-Committee, have envisioned creating a community to engage all members of PHM who identify as women. Their mission is to promote equity by creating a supportive venue for dialogue and education, developing opportunities for mentorship and career development, identify resources for work life integration, and by engaging, including, and collaborating with all members of PHM.
In August, Erika Friehling, MD, pediatric hematologist/oncologist at UPMC Children’s, was elected as a faculty representative to the University of Pittsburgh School of Medicine’s Executive Committee of the Faculty. Her service as a faculty representative began July 1, 2022 and will run through June 30, 2025.
In August, Jacqueline Ho, MD, MSc, was appointed as the new Pediatric Nephrology Division Chief. Dr. Ho succeeds Carlton M. Bates, MD, who retired at the end of June 2022. She joined the Division of Pediatric Nephrology at UPMC Children's in 2010. In addition to her clinical and research work, she has served as the director of the Pediatric Nephrology Fellowship program and co-director of the Pediatric Scientist Development Program in the Department of Pediatrics.
In June, Dwi Kemaladewi, PhD, received a R01 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the National Institute of Health (NIH). The R01 grant was titled “Therapeutic Genetics and Disease Modeling in LAMA2-deficient Congenital Muscular Dystrophy.” Dr. Kemaladewi’s team in the Division of Genetics and Genomic Medicine plans to use CRISPR activation technology to activate a gene called LAMA1 to compensate for the lack of LAMA2 in mouse and patient derived mod Collaborative Impact Award. This award was announced at the Pediatric Hospital Medicine (PHM) Conference in Orlando, Florida in July 2022.
In June, Geoffrey Kurland, MD, director of the Pediatric Lung Transplant Program at UPMC Children’s, received the ATS 2022 Pediatrics Assembly Lifetime Contributions to Pediatric Respiratory Medicine Award. Dr. Kurland’s clinical work has spanned the range of pediatric pulmonary conditions with an emphasis in pediatric lung transplantation, interstitial lung disease, and flexible bronchoscopy. Much of Dr. Kurland’s research over the years has involved interstitial lung disease in children and the development of novel approaches to lung transplant graft surveillance.
Anita McElroy, MD, PhD, pediatric infectious disease physician at UPMC Children's, received a R01 award from the National Institutes of Health (NIH) for her project titled “Innate immune recognition and response to Rift Valley fever virus.” Dr. McElroy and team are trying to determine how the mammalian host innate immune system recognizes and responds to RVFV infection and this modulates viral pathogenesis, and their central hypothesis is that differential innate immune recognition and response by infected cells modulates viral pathogenesis.
In August, Elizabeth Miller, MD, PhD, director of the Division of Adolescent and Young Adult Medicine and medical director of Community Health at UPMC Children’s, was hired as the new medical director for Adelphoi, one of Pennsylvania’s leading providers of services for at-risk youth and their families. In this role, she will serve as the physician responsible for the overall care and clinical practice carried out at Adelphoi.
An article entitled, “Nonprofit Board Membership: A Novel Mechanism for Authentic Community Engagement and Leadership Development for Resident Physicians” by Braveen Ragunanthan, MD, MPH, FAAP; Amy Nevin, MD, FAAP; Jennifer Wolford, DO, MPH; and Katherine Watson, DO, FAAP, was featured in Volume 14, Issue 3 of the Journal of Graduate Medicine Education. The article stresses the importance of genuine community engagement and leadership development for resident physicians in nonprofit board membership through their data and findings.
In August, the UPMC Children’s Heart Institute welcomed a new director of Noninvasive Cardiac Imaging, Laura J. Olivieri, MD. In addition to her role in the Heart Institute, Dr. Olivieri is an Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine Department of Pediatrics. Dr. Olivieri comes to UPMC Children’s and the University of Pittsburgh School of Medicine after having spent the last 15 years of her career at Children’s National Medical Center and George Washington University in Washington, D.C., where she was an associate professor of Pediatrics and director of the 3D Cardiac Visualization Laboratory and director of the Cardiac MR and CT Clinical Program. Dr. Olivieri’s clinical work and the focus of her research program have revolved around the use of cardiac imaging modalities, in particular cardiac magnetic resonance imaging, to advance and improve diagnostic capabilities and treatment approaches for a wide range of pediatric congenital cardiac anomalies and diseases.
In June, Raymond Pitetti, MD, MPH, FAAP, director of the division of Pediatric Emergency Medicine at UPMC Children’s, was appointed to the Faculty Assembly of the University Senate of University of Pittsburgh. Dr. Pitetti will be sitting under School of the Health Sciences under Medicine. His three-year term began on July 1. This election also includes membership on the Senate Council for the final two years of his term.
In August, Amanda Poholek, PhD, researcher and director of the Health Sciences Sequencing Core at UPMC Children’s, had her study titled “Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells” published in Science Immunology. Dr. Poholek, Greg Delgoffe, PhD, coauthor of the paper, and their team profiled molecular features of T cells as they progressed from early to terminal exhaustion in a mouse model of melanoma. They unexpectedly found that even the most terminally exhausted T cells retain some capacity to be functional again and identified approaches to overcome exhaustion, opening potential new avenues for cancer immunotherapy.
In August, Maya Ragavan, MD, MPH, MS, violence prevention researcher and pediatrician at UPMC Children's, received a K23 Mentored Patient-Oriented Research Career Development Award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Dr. Ragavan’s goal for her K23 award is to develop and test a strengths-based, culturally affirming dating violence prevention program for Latine adolescents and their parents or caregivers. She will start by conducting dyadic interviews with parents and adolescents, then design the intervention by adapting an existing program (Dating Matters for Parents), and finally conduct a pilot randomized clinical trial. Her work is in partnership with Salud Para Niños, a bilingual and bicultural pediatric medical home directed by Diego Chaves-Gnecco MD, MPH, and Casa San José, a resource and welcome center for Latine families.
In August, Mohamed Salah Emam Saleh, MD, pediatric endocrinologist at UPMC Children’s, received a KO8: Clinical Investigator Award from the NIH for his project “Loss of the Exocrine Pancreas Improves Glucose Tolerance and Insulin Secretion.” Dr. Saleh and team recently designed a surgical mouse model wherein a pancreatic ductal infusion of 1% acetic acid (AcA) led to complete ablation of the exocrine pancreas, but importantly with complete sparing of the islets. This model allowed them to study β-cell function in-situ in the pancreas, with the islets retaining their native innervation and vasculature, but in the absence of the exocrine pancreas.
Earlier this year, Amr Sawalha, MD, chief of the Division of Pediatric Rheumatology and a researcher in pediatric rheumatology at UPMC Children’s, received the Charles L. Christian Award for a Significant Advance in Understanding Lupus..
In September, Brittani Seynnaeve, MD, MS, director of the UPMC Pediatric Melanoma Program, associate fellowship program director of the UPMC Children’s Hospital of Pittsburgh Pediatric Hematology/Oncology Fellowship program, and assistant professor of medicine at the University of Pittsburgh School of Medicine, received a Melanoma and Skin Cancer Program Specialized Program of Research Excellence (MSCP SPORE) Career Enhancement Program (CEP) Award. She earned the award for her research titled “Defining the Telomere Length-Promoting Mutational Landscape and Associated Clinical Features of Pediatric, Adolescent, and Young Adult Melanoma.” The goal of this career enhancement program award is to provide support to advance disease classification and prognostication for pediatric and adolescent/young adult melanoma through multidisciplinary collaboration at the University of Pittsburgh with Jonathan Alder, PhD, combining his expertise in telomere biology with Seynnaeve’s clinical expertise in pediatric melanoma. This project utilizes resources from the UPMC Hillman Cancer Center Melanoma and Skin Cancer Program SPORE Biospecimen Core and the UPMC Pediatric Melanoma Program.